Compounds > n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and formazans

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with formazans in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, MF; Chen, SM; Chen, WC; Hong, JH; Hwang, TZ; Jung, SM; Lee, KF; Liao, SK; McBride, WH; Shau, H	1

Trials

1 trial(s) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and formazans

Article	Year
Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies. Head & neck, 2005, Volume: 27, Issue:6 Topics: Adult; Aged; Blotting, Western; Carcinoma; Combined Modality Therapy; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Formazans; Humans; Immunohistochemistry; In Vitro Techniques; Male; Membrane Proteins; Middle Aged; Nasopharyngeal Neoplasms; Nitrobenzenes; Prognosis; Prostaglandin-Endoperoxide Synthases; Radiation Tolerance; Sulfonamides; Survival Rate; Taiwan; Tetrazolium Salts; Tumor Cells, Cultured	2005

Article

Year

Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.

Head & neck, 2005, Volume: 27, Issue:6

Topics: Adult; Aged; Blotting, Western; Carcinoma; Combined Modality Therapy; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Female; Formazans; Humans; Immunohistochemistry; In Vitro Techniques; Male; Membrane Proteins; Middle Aged; Nasopharyngeal Neoplasms; Nitrobenzenes; Prognosis; Prostaglandin-Endoperoxide Synthases; Radiation Tolerance; Sulfonamides; Survival Rate; Taiwan; Tetrazolium Salts; Tumor Cells, Cultured

2005